Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
TSE:4554
Price:
1 529 JPY
0.72%
Updated:
May 15, 2024
Fuji Pharma Co Ltd
Interest Income Expense
|
Fuji Pharma Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fuji Pharma Co Ltd
TSE:4554
|
Interest Income Expense
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
58%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥164.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥11.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-19%
|
See Also
What is Fuji Pharma Co Ltd's Interest Income Expense?
Interest Income Expense
3.1B
JPY
3.1B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Interest Income Expense amounts to 3.1B JPY.
What is Fuji Pharma Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
58%
58%
Over the last year, the Interest Income Expense growth was 2 229%.
You don't have any saved screeners yet
